Clinical Trial Update: Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome

View source ↗

Summary

The document indicates that stiripentol has been approved for marketing and a plan to provide expanded-access treatment to patients with Dravet syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• Stiripentol (stiripentol)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Dravet Syndrome | Status: APPROVED_FOR_MARKETING